ADMA
ADMA Biologics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$9.62
+0.42%Margins
Gross margin
64.7%
EBITDA margin
45.8%
EBIT margin
42.3%
Net margin
33.0%
FCF margin
22.7%
41.4%
Return on equity
24.7%
Return on assets
35.4%
Return on invested capital
0.76x
Asset turnover
$136.7M
Cash from operations
$0.61
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026